Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.

Conclusions: The hus derived from the EQ-5D-3L is associated with all major cancer symptoms as captured by the esas. The esas scores alone could not predict EQ-5D scores with high accuracy. However, esas-derived questions assessing the same domains as the EQ-5D-3L questions could be mapped to their corresponding EQ-5D questions to generate the hus, with high correlation to the directly measured hus. That finding suggests a potential approach to integrating routine symptom and hus evaluations after confirmatory studies. PMID: 31896943 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31896943?dopt=Abstract

Source: Current Oncology - January 5, 2020 Category: Cancer & Oncology Tags: Curr Oncol Source Type: research